Kimia Biosciences Limited (BOM:530313)

India flag India · Delayed Price · Currency is INR
39.95
+5.15 (14.80%)
At close: Feb 13, 2026
Market Cap1.89B -6.8%
Revenue (ttm)1.26B +17.7%
Net Income81.81M +182.7%
EPS1.73 +184.2%
Shares Out47.31M
PE Ratio23.12
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume93,385
Average Volume10,732
Open34.10
Previous Close34.80
Day's Range33.60 - 41.76
52-Week Range26.09 - 86.85
Beta0.68
RSI76.69
Earnings DateFeb 14, 2026

About Kimia Biosciences

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its prod... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1993
Employees 250
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530313
Full Company Profile

Financial Performance

Financial Statements